Evidently Secures $15M Series A Funding from DN Capital

Deal News | Jan 10, 2025 | DN Capital Limited

Evidently Secures $15M Series A Funding from DN Capital

DN Capital Limited has spearheaded a $15 million Series A funding round in Evidently, an innovative platform dedicated to transforming the healthcare industry. Evidently's technology seeks to synthesize fragmented medical data from various sources, converting this information into actionable insights that can dramatically improve the efficiency and effectiveness of hospitals and large health systems. The investment, which was oversubscribed, highlights DN Capital’s confidence in Evidently’s potential and the exceptional caliber of its founding team. This infusion of funds aims to support Evidently's ongoing development and expand its capacity to deliver cutting-edge AI-driven solutions within the healthcare sector. The move underscores the increasing interest of private equity in digital health technologies and its potential to significantly impact patient care and institutional efficiencies.

Sectors

  • Healthcare
  • Technology
  • Private Equity

Geography

  • Global – The nature of Evidently's technology suggests a broad applicability across multiple regions, positioning the company in a global healthcare technology marketplace.

Industry

  • Healthcare – The article focuses on Evidently, a company that operates within the healthcare industry by providing AI solutions to hospitals and large health systems.
  • Technology – Evidently utilizes AI to synthesize medical data, indicating its position at the intersection of the technology industry focused on healthcare advancements.
  • Private Equity – DN Capital Limited's investment in Evidently situates the article within the private equity sector, emphasizing financial backing and strategic investment in healthcare innovation.

Financials

  • $15M – The amount raised in the Series A funding round led by DN Capital.

Participants

NameRoleTypeDescription
EvidentlyTarget CompanyCompanyAn AI platform focused on transforming medical data into actionable insights for healthcare systems.
DN Capital LimitedBidding CompanyCompanyA private equity firm leading the Series A investment in Evidently.